Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Analytical Community Rewards Postnova System with 2012 Innovations Award

Published: Monday, December 17, 2012
Last Updated: Monday, December 17, 2012
Bookmark and Share
The new CF2000 Series for high-resolution separation and fractionation of nanoparticles has won the prestigious GIT Innovations Award 2012 in the category ‘Analytical Instrumentation and Software’.

The Postnova team are the inventors of the Field-Flow Fractionation (FFF) technique, and developed the CF2000 to be the first Centrifugal FFF system for routine use.

Dr Thorsten Klein, Founder and CEO, Postnova, said: “It is a great honour to receive this award. To be acknowledged by scientists working at the bench is particularly important for us as it shows that our innovative products are recognized as powerful practical tools for daily analysis, exactly what we designed them to be. I would like to thank the publishers at G.I.T. Verlag for sponsoring the award, the independent jury who placed the CF2000 on the shortlist and, most of all, everyone who took the time to vote for us online, at Analytica, and at Achema.”

The CF2000 is modular, allowing for a range of different detectors: Multi-Angle Light Scattering (MALS) , Dynamic Light Scattering (DLS) and Refractive Index (RI), for example, to be integrated. Whatever the configuration, everything from autosampler to detector is fully controlled by the NovaFFF software platform.
Importantly, by using a centrifugal field as the controlling force for the separation, particles are separated by Dynamic Diffusion on the basis of size and density. This novel approach allows discrimination of materials that have the same particle size but different densities.

The CF2000 has a wide operation range and is able to separate smaller species, such as proteins and polymers, from larger particles in one run with high resolution. The system is ideal for nanoparticles and works up into the microparticle size range too. No special sample treatment is necessary, allowing challenging biopharmaceutical, food-cosmetics, nanomaterial and environmental samples to be characterized.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos